Identification of <i>HE1</i> as the Second Gene of Niemann-Pick C Disease

Saule Naureckiene(Advanced Pharma), David E. Sleat(Johnson University), Henry Lackland(Advanced Pharma), Anthony H. Fensom(Guy's Hospital), Marie T. Vanier(Inserm), Robert Wattiaux(University of Namur), Michel Jadot(University of Namur), Peter Lobel(Johnson University)
Science
December 22, 2000
Cited by 829

Abstract

Niemann-Pick type C2 disease (NP-C2) is a fatal hereditary disorder of unknown etiology characterized by defective egress of cholesterol from lysosomes. Here we show that the disease is caused by a deficiency in HE1, a ubiquitously expressed lysosomal protein identified previously as a cholesterol-binding protein. HE1 was undetectable in fibroblasts from NP-C2 patients but present in fibroblasts from unaffected controls and NP-C1 patients. Mutations in the HE1 gene, which maps to chromosome 14q24.3, were found in NP-C2 patients but not in controls. Treatment of NP-C2 fibroblasts with exogenous recombinant HE1 protein ameliorated lysosomal accumulation of low density lipoprotein-derived cholesterol.


Related Papers

No related papers found

Powered by citation graph analysis